Radiogenomic Signatures of Oncotype DX Recurrence Score Enable Prediction of Survival in Estrogen Receptor–Positive Breast Cancer: A Multicohort Study

Ming Fan, Yajing Cui, Chao You, Li Liu, Yajia Gu, Weijun Peng, Qianming Bai, Xin Gao, Lihua Li

Research output: Contribution to journalArticlepeer-review

Abstract

Radiogenomic signatures associated with genomic assays (Oncotype DX) were identified as independent predictors after adjusting for clinical factors for survival and neoadjuvant chemotherapy response in estrogen receptor–positive breast cancer.
Original languageEnglish (US)
JournalRadiology
DOIs
StatePublished - Nov 30 2021

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Radiogenomic Signatures of Oncotype DX Recurrence Score Enable Prediction of Survival in Estrogen Receptor–Positive Breast Cancer: A Multicohort Study'. Together they form a unique fingerprint.

Cite this